About
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services comprising patient care, psychological support, nutrition and dietetics, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology, CAR T cell, translational and nuclear medicine, oncodermatology, anaesthesiology, paediatric and gynaecologic oncology, orthopaedic oncology, uro-oncology, infectious diseases, gastrointestinal and thoracic oncology, breast surgical oncology, clinical pharmacology, and pain and palliative services. In addition, the company operates multi-specialty hospitals under the HCG brand that offers inpatient and outpatient treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. Further, it provides oncology diagnostics services, including biomarker and translational research, and clinical research services under the Triesta Sciences brand; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.
Key Metrics
as of Sep 2026Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 376.66 | 350.21 | 342.16 | 345.84 | 327.09 | 324.38 | 312.51 | 329.25 | 293.61 | 299.93 | 285.81 | 282.75 | 272.23 |
| Expenses | 317.44 | 275.07 | 287.86 | 283.54 | 277.24 | 265.49 | 270.19 | 267.67 | 243.72 | 243.32 | 237.06 | 232.34 | 224.69 |
| Operating Profit | 59.22 | 75.14 | 54.30 | 62.30 | 49.85 | 58.89 | 42.32 | 61.58 | 49.89 | 56.61 | 48.75 | 50.41 | 47.54 |
| OPM % | 15.72 | 21.46 | 15.87 | 18.01 | 15.24 | 18.15 | 13.54 | 18.70 | 16.99 | 18.87 | 17.06 | 17.83 | 17.46 |
| Other Income | 9.56 | -32.60 | -4.87 | 3.82 | 7.94 | 9.46 | -29.53 | 9.79 | 10.50 | -12.43 | 5.04 | 2.13 | 1.83 |
| Depreciation | 39.57 | 31.30 | 30.09 | 30.16 | 28.25 | 29.05 | 27.90 | 27.88 | 25.84 | 25.90 | 24.80 | 23.28 | 21.64 |
| Interest | 21.73 | 20.19 | 20.61 | 21.36 | 24.30 | 22.50 | 21.27 | 20.58 | 19.34 | 14.61 | 13.70 | 10.98 | 9.69 |
| Profit before tax | 7.48 | -8.95 | -1.27 | 14.60 | 5.24 | 16.80 | -36.38 | 22.91 | 15.21 | 3.67 | 15.29 | 18.28 | 18.04 |
| Tax % | 25.40 | -117.09 | -7.09 | 26.16 | 34.16 | 39.58 | 2.61 | 21.65 | 22.95 | 145.78 | 43.30 | 25.05 | 24.11 |
| Net Profit | 5.58 | 1.53 | -1.18 | 10.78 | 3.45 | 10.15 | -37.33 | 17.95 | 11.72 | -1.68 | 8.67 | 13.70 | 13.69 |
| EPS in Rs | 0.37 | 0.10 | -0.08 | 0.72 | 0.23 | 0.69 | -2.53 | 1.22 | 0.79 | -0.11 | 0.59 | 0.93 | 0.93 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,359.00 | 1,277.00 | 1,171.00 | 1,006.00 | 850.00 | 609.00 | 688.00 | 640.00 | 586.00 | 545.00 | 471.00 | 420.00 |
| Expenses | 1,124.00 | 1,065.00 | 970.00 | 824.00 | 703.00 | 535.00 | 573.00 | 546.00 | 498.00 | 462.00 | 407.00 | 364.00 |
| Operating Profit | 236.00 | 211.00 | 201.00 | 181.00 | 147.00 | 74.00 | 116.00 | 94.00 | 88.00 | 83.00 | 64.00 | 56.00 |
| OPM % | 17.00 | 17.00 | 17.00 | 18.00 | 17.00 | 12.00 | 17.00 | 15.00 | 15.00 | 15.00 | 14.00 | 13.00 |
| Other Income | -20.00 | 4.00 | 0.00 | 7.00 | 65.00 | -129.00 | -19.00 | 13.00 | 19.00 | 7.00 | -1.00 | 0.00 |
| Interest | 86.00 | 84.00 | 50.00 | 41.00 | 43.00 | 63.00 | 83.00 | 48.00 | 27.00 | 16.00 | 34.00 | 32.00 |
| Depreciation | 120.00 | 111.00 | 97.00 | 89.00 | 88.00 | 87.00 | 79.00 | 47.00 | 44.00 | 44.00 | 37.00 | 33.00 |
| Profit before tax | 10.00 | 20.00 | 54.00 | 58.00 | 81.00 | -205.00 | -65.00 | 13.00 | 37.00 | 29.00 | -9.00 | -8.00 |
| Tax % | -52.00 | 82.00 | 39.00 | 30.00 | 53.00 | -7.00 | -19.00 | 42.00 | 32.00 | 34.00 | -45.00 | -69.00 |
| Net Profit | 15.00 | 4.00 | 33.00 | 40.00 | 38.00 | -192.00 | -53.00 | 7.00 | 25.00 | 19.00 | -5.00 | -2.00 |
| EPS in Rs | 0.98 | 0.24 | 2.22 | 2.73 | 2.60 | -14.43 | -5.68 | 0.78 | 2.71 | 2.15 | -0.52 | -0.32 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 149.00 | 139.00 | 139.00 | 139.00 | 139.00 | 125.00 | 89.00 | 88.00 | 87.00 | 86.00 | 85.00 | 70.00 |
| Reserves | 1,455.00 | 1,052.00 | 1,042.00 | 1,006.00 | 959.00 | 798.00 | 526.00 | 557.00 | 552.00 | 459.00 | 435.00 | 202.00 |
| Borrowings | 1,022.00 | 1,118.00 | 758.00 | 347.00 | 349.00 | 481.00 | 827.00 | 422.00 | 264.00 | 218.00 | 194.00 | 311.00 |
| Other Liabilities | 291.00 | 295.00 | 299.00 | 237.00 | 197.00 | 169.00 | 328.00 | 337.00 | 210.00 | 159.00 | 136.00 | 107.00 |
| Total Liabilities | 2,917.00 | 2,604.00 | 2,239.00 | 1,730.00 | 1,644.00 | 1,575.00 | 1,769.00 | 1,404.00 | 1,112.00 | 923.00 | 850.00 | 690.00 |
| Fixed Assets | 1,122.00 | 1,038.00 | 974.00 | 788.00 | 774.00 | 745.00 | 914.00 | 547.00 | 492.00 | 442.00 | 431.00 | 405.00 |
| CWIP | 14.00 | 23.00 | 36.00 | 9.00 | 5.00 | 28.00 | 44.00 | 104.00 | 79.00 | 33.00 | 29.00 | 28.00 |
| Investments | 704.00 | 696.00 | 506.00 | 475.00 | 439.00 | 366.00 | 316.00 | 299.00 | 219.00 | 141.00 | 155.00 | 84.00 |
| Other Assets | 1,078.00 | 847.00 | 722.00 | 458.00 | 426.00 | 436.00 | 495.00 | 454.00 | 322.00 | 306.00 | 235.00 | 173.00 |
| Total Assets | 2,917.00 | 2,604.00 | 2,239.00 | 1,730.00 | 1,644.00 | 1,575.00 | 1,769.00 | 1,404.00 | 1,112.00 | 923.00 | 850.00 | 690.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 160.00 | 146.00 | 209.00 | 130.00 | 124.00 | 71.00 | 86.00 | 87.00 | 66.00 | 54.00 | 58.00 | 51.00 |
| Cash from Investing Activity | -76.00 | -347.00 | -254.00 | -138.00 | 49.00 | -246.00 | -116.00 | -208.00 | -185.00 | -73.00 | -86.00 | -74.00 |
| Cash from Financing Activity | 336.00 | -42.00 | 96.00 | -42.00 | -41.00 | 236.00 | -3.00 | 66.00 | 91.00 | -14.00 | 120.00 | 22.00 |
| Net Cash Flow | 421.00 | -243.00 | 51.00 | -49.00 | 132.00 | 61.00 | -32.00 | -55.00 | -27.00 | -33.00 | 92.00 | -1.00 |
| Free Cash Flow | 8.00 | 13.00 | 80.00 | 36.00 | 82.00 | 48.00 | 6.00 | -36.00 | -37.00 | 18.00 | -32.00 | -17.00 |
| CFO/OP % | 72.00 | 78.00 | 121.00 | 81.00 | 95.00 | 41.00 | 92.00 | 120.00 | 74.00 | 74.00 | 102.00 | 90.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70.00 | 75.00 | 69.00 | 77.00 | 69.00 | 88.00 | 81.00 | 83.00 | 79.00 | 67.00 | 54.00 | 56.00 |
| Inventory Days | 26.00 | 23.00 | 30.00 | 33.00 | 30.00 | 32.00 | 31.00 | 39.00 | 40.00 | 36.00 | 30.00 | 36.00 |
| Days Payable | 168.00 | 175.00 | 192.00 | 168.00 | 167.00 | 214.00 | 247.00 | 253.00 | 269.00 | 257.00 | 266.00 | 208.00 |
| Cash Conversion Cycle | -71.00 | -77.00 | -93.00 | -59.00 | -68.00 | -94.00 | -135.00 | -131.00 | -150.00 | -154.00 | -182.00 | -116.00 |
| Working Capital Days | -33.00 | -70.00 | -37.00 | 26.00 | 9.00 | 38.00 | -133.00 | -82.00 | -24.00 | -69.00 | -74.00 | -64.00 |
| ROCE % | 6.00 | 7.00 | 7.00 | 7.00 | 5.00 | 1.00 | 4.00 | 6.00 | 7.00 | 6.00 | 5.00 | 5.00 |
Corporate Actions
8 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Rights | 02 Mar 2026 | 02 Mar 2026 | 1:17 | — | |
| Other | 02 Mar 2026 | 02 Mar 2026 | — | — | Right Issue of Equity Shares |
| Other | 22 Sep 2022 | — | — | — | Annual General Meeting |
| Other | 23 Sep 2021 | — | — | — | Annual General Meeting |
| Other | 19 Sep 2019 | — | — | — | Annual General Meeting |
| Other | 19 Sep 2018 | — | — | — | Annual General Meeting |
| Other | 03 Aug 2017 | — | — | — | Annual General Meeting |
| Other | 22 Sep 2016 | — | — | — | Annual General Meeting |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update25 Mar from icra
-
Rating update7 Jan from care
-
Rating update5 Mar 2025 from icra
-
Rating update4 Mar 2025 from care
-
Rating update10 Jan 2025 from care
-
Rating update31 Dec 2024 from icra
Conference Calls
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript